Skip to main content

Aptevo Therapeutics Inc 10-Q for FY2026 Q3

Aptevo Therapeutics Inc. (APVO)

10-Q 2026-11-16 For: 2026-09-30
View Original
Added on November 16, 2026

About this 10-Q

Aptevo Therapeutics Inc filed this 10-Q on November 16, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Aptevo held $8.3 million of cash as of September 30, 2026, versus $19.1 million of operating cash use for the nine months ended September 30, 2026, and said existing resources will not fund operations for at least one year. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$6.55M
compared with a net loss of $7.55M a year earlier
Diluted EPS
-$5.19
compared with -$40.13 a year earlier